Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials
Abstract Background IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. A Proliferation-Inducing Ligand (APRIL) plays a critical role in the development and progression of IgAN. This study aimed to evaluate the efficacy and safety of sibeprenlimab, an APRIL receptor antag...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-03-01
|
| coleção: | BMC Nephrology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12882-026-04927-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|